Barré for every million doses given.
Before the RSV vaccines were approved, the FDA flagged potential GBS risks with the vaccines. After approval, the CDC ...
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...
A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s ...
“As of December 28, Oneida County has had 386 flu cases reported since the flu season began,” said Daniel W. Gilmore, Ph.D., ...
The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...
Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.
Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...
He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...
For RSV in particular, nearly two dozen states are currently reporting high levels, according to the U.S. Centers for Disease ...